We recently published a list of The Best and Worst Dow Stocks for the Next 12 Months. In this article, we are going to take a ...

Amgen (NasdaqGS:AMGN) recently announced a significant $900 million expansion in its Ohio manufacturing facility, aiming to ...

Amgen’s product sales are expected to have been driven by strong volume growth of products like Evenity, Repatha, Kyprolis ...

Amgen (NASDAQ:AMGN) today announced that it will report its first quarter 2025 financial results on Thursday, May 1, 2025, after the close of the U.S. financial markets. The announcement will be ...

Amgen (NASDAQ:AMGN) is set to report its Q1 earnings results on Thursday, May 1st, after the market closes. Street ...

The Small Cell Lung Cancer market report also offers comprehensive insights into the Small Cell Lung Cancer market size, ...

Key growth drivers include major biologics' patent expirations and cost-effectiveness, while European market leads with 45.8% share in 2023.Dublin, April 30, 2025 (GLOBE NEWSWIRE) -- The "Biosimilars: ...

Burling Wealth Partners LLC added 929 shares of Amgen to its portfolio in Q4, worth about $242,000—a modest but calculated ...

Alvotech faces challenges with potential tariffs and profitability, despite strong revenue growth and a robust pipeline. See ...

Amgen's shares fell late last year when its ... Apoquel still has plenty of room to grow its market share, despite competition, and Zoetis will rely on other new approvals to drive top-line ...

In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Amgen (AMGN – Research Report), with a price target of ...

Amgen discovers, develops ... largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.